174 related articles for article (PubMed ID: 37093598)
21. Analysis of prevalence and degree of macrocephaly in patients with germline PTEN mutations and of brain weight in Pten knock-in murine model.
Mester JL; Tilot AK; Rybicki LA; Frazier TW; Eng C
Eur J Hum Genet; 2011 Jul; 19(7):763-8. PubMed ID: 21343951
[TBL] [Abstract][Full Text] [Related]
22. WWP1 Gain-of-Function Inactivation of PTEN in Cancer Predisposition.
Lee YR; Yehia L; Kishikawa T; Ni Y; Leach B; Zhang J; Panch N; Liu J; Wei W; Eng C; Pandolfi PP
N Engl J Med; 2020 May; 382(22):2103-2116. PubMed ID: 32459922
[TBL] [Abstract][Full Text] [Related]
23. Development of informant-report neurobehavioral survey scales for PTEN hamartoma tumor syndrome and related neurodevelopmental genetic syndromes.
Frazier TW; Busch RM; Klaas P; Lachlan K; Jeste S; Kolevzon A; Loth E; Harris J; Speer L; Pepper T; Anthony K; Graglia JM; Delagrammatikas C; Bedrosian-Sermone S; Beekhuyzen J; Smith-Hicks C; Sahin M; Eng C; Hardan AY; Uljarević M
Am J Med Genet A; 2023 Jul; 191(7):1741-1757. PubMed ID: 37045800
[TBL] [Abstract][Full Text] [Related]
24. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
25. The microbiome in
Byrd V; Getz T; Padmanabhan R; Arora H; Eng C
Endocr Relat Cancer; 2018 Mar; 25(3):233-243. PubMed ID: 29233840
[TBL] [Abstract][Full Text] [Related]
26. Yield of annual endometrial cancer surveillance in women with PTEN Hamartoma Tumor Syndrome.
Kwinten KJJ; Drissen MMCM; de Hullu JA; Vos JR; Hoogerbrugge N; van Altena AM
Eur J Med Genet; 2023 Jul; 66(7):104785. PubMed ID: 37172779
[TBL] [Abstract][Full Text] [Related]
27. Exome sequencing reveals a distinct somatic genomic landscape in breast cancer from women with germline PTEN variants.
Brewer T; Yehia L; Bazeley P; Eng C
Am J Hum Genet; 2022 Aug; 109(8):1520-1533. PubMed ID: 35931053
[TBL] [Abstract][Full Text] [Related]
28. PTEN Hamartoma Tumor Syndrome: A Case of Renal Cell Carcinoma in a Young Female.
Ramkumar RR; Murthy PB; Nguyen JK; McKenney J; Eng C; Campbell SC
Urology; 2021 Feb; 148():113-117. PubMed ID: 33227300
[TBL] [Abstract][Full Text] [Related]
29. Long-term treatment of cancer-prone germline PTEN mutant mice with low-dose rapamycin extends lifespan and delays tumour development.
Tibarewal P; Rathbone V; Constantinou G; Pearce W; Adil M; Varyova Z; Folkes L; Hampson A; Classen GAE; Alves A; Carvalho S; Scudamore CL; Vanhaesebroeck B
J Pathol; 2022 Dec; 258(4):382-394. PubMed ID: 36073856
[TBL] [Abstract][Full Text] [Related]
30. Red flags for early recognition of adult patients with PTEN Hamartoma Tumour Syndrome.
Drissen MMCM; Schieving JH; Schuurs-Hoeijmakers JHM; Vos JR; Hoogerbrugge N
Eur J Med Genet; 2021 Dec; 64(12):104364. PubMed ID: 34637944
[TBL] [Abstract][Full Text] [Related]
31. Cancer risk and genotype-phenotype correlations in PTEN hamartoma tumor syndrome.
Nieuwenhuis MH; Kets CM; Murphy-Ryan M; Yntema HG; Evans DG; Colas C; Møller P; Hes FJ; Hodgson SV; Olderode-Berends MJ; Aretz S; Heinimann K; Gómez García EB; Douglas F; Spigelman A; Timshel S; Lindor NM; Vasen HF
Fam Cancer; 2014 Mar; 13(1):57-63. PubMed ID: 23934601
[TBL] [Abstract][Full Text] [Related]
32. The Clinical Spectrum of PTEN Hamartoma Tumor Syndrome: Exploring the Value of Thyroid Surveillance.
Baran JA; Tsai SD; Isaza A; Brodeur GM; MacFarland SP; Zelley K; Adams DM; Franco AT; Bauer AJ
Horm Res Paediatr; 2020; 93(11-12):634-642. PubMed ID: 33887726
[TBL] [Abstract][Full Text] [Related]
33.
Schultz KAP; Rednam SP; Kamihara J; Doros L; Achatz MI; Wasserman JD; Diller LR; Brugières L; Druker H; Schneider KA; McGee RB; Foulkes WD
Clin Cancer Res; 2017 Jun; 23(12):e76-e82. PubMed ID: 28620008
[No Abstract] [Full Text] [Related]
34. PTEN germline mutations in patients initially tested for other hereditary cancer syndromes: would use of risk assessment tools reduce genetic testing?
Mester JL; Moore RA; Eng C
Oncologist; 2013; 18(10):1083-90. PubMed ID: 24037976
[TBL] [Abstract][Full Text] [Related]
35. Thyroid pathology in PTEN-hamartoma tumor syndrome: characteristic findings of a distinct entity.
Laury AR; Bongiovanni M; Tille JC; Kozakewich H; Nosé V
Thyroid; 2011 Feb; 21(2):135-44. PubMed ID: 21190448
[TBL] [Abstract][Full Text] [Related]
36. Thyroid disease in children and adolescents with PTEN hamartoma tumor syndrome (PHTS).
Plamper M; Schreiner F; Gohlke B; Kionke J; Korsch E; Kirkpatrick J; Born M; Aretz S; Woelfle J
Eur J Pediatr; 2018 Mar; 177(3):429-435. PubMed ID: 29273943
[TBL] [Abstract][Full Text] [Related]
37. Considerations on diagnosis and surveillance measures of PTEN hamartoma tumor syndrome: clinical and genetic study in a series of Spanish patients.
Pena-Couso L; Ercibengoa M; Mercadillo F; Gómez-Sánchez D; Inglada-Pérez L; Santos M; Lanillos J; Gutiérrez-Abad D; Hernández A; Carbonell P; Letón R; Robledo M; Rodríguez-Antona C; Perea J; Urioste M;
Orphanet J Rare Dis; 2022 Feb; 17(1):85. PubMed ID: 35227301
[TBL] [Abstract][Full Text] [Related]
38. The yield and effectiveness of breast cancer surveillance in women with PTEN Hamartoma Tumor Syndrome.
Hoxhaj A; Drissen MMCM; Vos JR; Bult P; Mann RM; Hoogerbrugge N
Cancer; 2022 Aug; 128(15):2883-2891. PubMed ID: 36533707
[TBL] [Abstract][Full Text] [Related]
39. Benign goiters requiring thyroidectomy as the signal for PTEN hamartoma tumor syndrome diagnosis.
Wang X; Moore C; Bao Y
Am J Med Genet A; 2023 Mar; 191(3):753-759. PubMed ID: 36453251
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
